CBD and migraine: what does the research actually say?

Anyone who gets migraines knows the drill: the search for something, anything, that takes the edge off before the pain takes over the whole day. Over the past few years, CBD has entered that search alongside the usual suspects. But how much of that is genuine science, and how much is wishful thinking? Here's an honest look at what researchers have found so far.

Migraine is more than "a bad headache"

Migraine is a neurological condition, not just an intense headache. It typically involves throbbing pain, often on one side of the head, along with nausea, and heightened sensitivity to light and sound. Some people also experience an "aura," visual or sensory disturbances that precede the attack. Episodes can last anywhere from a few hours to several days, and for people with chronic migraine, that can mean 15 or more headache days a month.

Standard treatment splits into two categories: acute medication taken during an attack (like triptans or NSAIDs), and preventive medication taken daily to reduce frequency. Both categories work for many people, but far from everyone, which is exactly why so many migraine sufferers end up exploring alternatives.

The theory: why cannabinoids might matter for migraine

There's a long-standing scientific hypothesis, first proposed by researcher Ethan Russo, called "clinical endocannabinoid deficiency." The idea is that some chronic pain conditions, including migraine, fibromyalgia, and irritable bowel syndrome, might be linked to lower-than-normal levels or activity of the body's own endocannabinoids. Supporting this, researchers measuring spinal fluid in people with chronic migraine found lower levels of anandamide, one of the body's key endocannabinoid signaling molecules, compared to people without migraine.

Anandamide has documented effects on brain regions and receptors involved in migraine, including a brainstem area known as a "migraine generator." That's given researchers a plausible biological reason to investigate whether supporting the endocannabinoid system, including with plant-derived cannabinoids like CBD, could play a role in migraine management. It's worth being clear, though: this is a hypothesis with growing supporting evidence, not an established mechanism.

What the clinical evidence actually shows

This is where honesty matters most. Most of the strongest clinical evidence for cannabinoids and migraine comes from studies combining CBD with THC, not CBD by itself.

A randomized, placebo-controlled trial presented at the American Academy of Neurology's 2024 meeting found that a vaporized mix of THC and CBD provided meaningful relief for acute migraine attacks, with benefits still present at 24 and 48 hours. A separate randomized crossover trial found that a combination containing roughly 6% THC and 11% CBD outperformed placebo for pain relief and freedom from migraine symptoms. Large observational surveys have also found that people using inhaled cannabis (again, typically containing both THC and CBD) report meaningful drops in headache and migraine severity.

CBD used on its own, without THC, has considerably less direct migraine-specific research behind it. One notable exception: a randomized trial using topical CBD gel in people with bruxism-related jaw pain found improvements in both sleep quality and migraine-related disability scores, suggesting a possible secondary effect through better sleep and reduced muscle tension rather than a direct anti-migraine action. Separately, a pediatric tolerability trial (CAN-CHA) is currently underway in Canada testing a CBD-dominant extract for chronic migraine in adolescents, but that trial is assessing safety and dosing, not yet proving effectiveness.

In short: cannabinoids, especially combined with THC, show real promise for migraine in early clinical trials. CBD in isolation is more of an open question, with laboratory research suggesting plausible mechanisms (anti-inflammatory effects, an influence on serotonin receptors involved in migraine) but far less direct clinical proof than the combination products.

What this means if you're considering CBD for migraine

If you're dealing with migraine and thinking about trying CBD, a few things are worth keeping in mind:

• This isn't a replacement for diagnosis. Migraine should be diagnosed and monitored by a doctor, especially since some headache patterns can signal something more serious.
• Start low and track your response. Everyone's endocannabinoid system responds differently, and migraine is notoriously individual in what helps and what doesn't.
• Consider the full picture, not just the attack itself. Since sleep disruption and muscle tension are closely tied to migraine frequency for many people, CBD's more consistently documented effects on sleep and relaxation may be part of why some people report benefit, even without direct anti-migraine action.
• Talk to your doctor if you're on migraine medication. CBD can interact with certain medications, including some used for migraine prevention.

Important: CBD and hemp products are not a substitute for medical treatment. Migraine is a neurological condition that should be diagnosed and monitored by a doctor or neurologist. Always consult your healthcare provider before starting or changing any treatment, especially if you are on existing medication.

References

1. Sarchielli, P., Pini, L.A., Coppola, F. et al. Endocannabinoids in Chronic Migraine: CSF Findings Suggest a System Failure. Neuropsychopharmacology (2007). Summarized in: Russo, E.B. Clinical Endocannabinoid Deficiency Reconsidered. Cannabis and Cannabinoid Research (2016). ncbi.nlm.nih.gov/pmc/articles/PMC5576607
2. Schuster, N.M. et al. Vaporized THC-CBD for acute migraine, presented at American Academy of Neurology 2024 Annual Meeting. medscape.com/viewarticle/vaporized-cannabis-acute-migraine-yields-rapid-sustained-2024a10007fb
3. Randomized, double-blind, placebo-controlled crossover trial of THC/CBD combination for acute migraine (NCT04360044), reported via NeurologyLive. neurologylive.com/view/final-analyses-highlight-efficacy-thc-cbd-combination-therapy-acute-migraine
4. Expanding the Therapeutic Profile of Topical Cannabidiol in Temporomandibular Disorders: Effects on Sleep Quality and Migraine Disability. ncbi.nlm.nih.gov/pmc/articles/PMC12300357
5. A Multi-Centre Tolerability Study of a Cannabidiol-enriched Cannabis Herbal Extract for Chronic Headaches in Adolescents (CAN-CHA Protocol). ncbi.nlm.nih.gov/pmc/articles/PMC11414974
6. Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine. ncbi.nlm.nih.gov/pmc/articles/PMC10155373